BridgeMD
New treatment option for Molar, Third
Official title Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars
ClinicalTrials.gov ID: NCT05924191
What this study is testing
What is Corticosteroid?
Corticosteroid is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for molar, third.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Third molar extraction is one of the most performed surgical procedures in Dentistry. A comfortable postoperative period and rapid return to daily activities increase the need to control the inflammatory response and its signs and symptoms such as pain, edema, and lockjaw.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Patients who present retained lower third molars, according to the degree of surgical difficulty of the procedure and the anatomical position.The...
- That have an indication for the extraction of the lower third molars (due to recurrent infections, bad anatomical position, orthodontic indication)...
- Male or female gender.
- Age between 18 and 50 years.
- Good oral hygiene.
You likely can't join if
- Carriers of local alterations that contraindicate surgical intervention or complicate the postoperative period (example: acute phase pericoronitis in...
- Smokers,
- Presenting absence of upper and lower central incisors,
- With a medical history of photosensitivity
- During pregnancy or lactation,
- That they were using anti-inflammatories or analgesics,
See the full eligibility criteria
- Patients who present retained lower third molars, according to the degree of surgical difficulty of the procedure and the anatomical position.The selected molars will be those classified according to classes II and III...
- That have an indication for the extraction of the lower third molars (due to recurrent infections, bad anatomical position, orthodontic indication) or a professional indication presented in writing and that are healthy...
- Male or female gender.
- Age between 18 and 50 years.
- Good oral hygiene.
- That they agree to participate in the study, after reading and signing the Informed Consent for participation in clinical research.
- Carriers of local alterations that contraindicate surgical intervention or complicate the postoperative period (example: acute phase pericoronitis in the last 30 days, ankylosis of the temporomandibular joint).
- Smokers,
- Presenting absence of upper and lower central incisors,
- With a medical history of photosensitivity
- During pregnancy or lactation,
- That they were using anti-inflammatories or analgesics,
- Allergic to any of the drugs used in the research (amoxicillin, ketorolac, acetaminophen, dexamethasone, chlorhexidine 2%, local anesthetics, sodium bisulfite, etc.)
- That during surgery they present any type of complication (bleeding, transoperative difficulties, etc.), because these cases are not included within the expected pattern behavior for this type of surgery (these cases...
- Surgical time greater than 90 minutes.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.